Clicky

Olink Holding AB(OLK)

Description: Olink Holding AB (publ) provides products and services for human protein biomarker discovery worldwide. Its Olink Explore product line include protein biomarker assays primarily for cardiovascular and metabolic diseases, oncology, neurology, and inflammation; Olink Target product line comprise human protein biomarkers for monitoring immune system and downstream applications in clinical trials; and Olink Focus product line consists of custom developed solutions for customers that have identified a small number of proteins of interest, or a protein signature. The company also offers Olink Signature Q100, a qPCR readout platform for proximity extension assay; Olink NPX Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of normalized protein expression (NPX) data. In addition, it provides Olink Analysis service comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. The company was founded in 2016 and is headquartered in Uppsala, Sweden.


Keywords: Natural Sciences Biotechnology Biology Inflammation Molecular Biology Data Processing Biomarkers Laboratory Techniques Gene Expression Assay Bioinformatics Polymerase Chain Reaction Real Time Polymerase Chain Reaction Bioinformatics Services Cardiovascular And Metabolic Diseases Downstream Applications

Home Page: www.olink.com

OLK Technical Analysis

Uppsala Science Park
Uppsala, 751 83
Sweden
Phone: 46 1 84 44 39 70


Officers

Name Title
Mr. Jon Heimer CEO & Director
Mr. Oskar Hjelm Chief Financial Officer
Ms. Anna Marsell Chief Operating Officer
Dr. Ida Grundberg Ph.D. Chief Scientific Officer
Mr. Jan Medina CFA VP of Investor Relations & Capital Markets
Ms. Linda Ramirez-Eaves Esq. Gen. Counsel
Andrea Prander Corp. Communications Mang.
Ms. Johanna Isander Chief People Officer
Mr. Rickard El Tarzi Chief Strategy Officer
Mr. Carl Raimond Chief Commercial Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 6.9089
Price-to-Sales TTM: 21.7066
IPO Date: 2021-03-25
Fiscal Year End: December
Full Time Employees: 416
Back to stocks